What Awaits Healthcare Stocks ESRX and EPZM in Q1 Earnings?
Zacks Investment Research | Apr 22, 2016 12:16AM ET
Investors around the world are seeing a ray of hope as the first-quarter earnings season kicked off on an encouraging note. With the downturn in China and falling oil prices weighing on the market since the start of 2016, investors were jittery when the companies started reporting results. In particular, the healthcare sector came under the scanner after Democratic Presidential candidate Hillary Clinton’s tweet on price hike reignited the debate on the massive drug price increase by companies, leading to a huge sell-off in the latter half of 2015. Other factors such as foreign exchange rates, biosimilars and generic competition continue to hurt the performance of this sector as well.
Interestingly, so far, results were not as dismal as analysts had estimated, with many companies reporting positive surprises for both the top- and bottom-line numbers. However, we are still in the early phase of the season and caution remains the keyword, going ahead. As per our Epizyme Q1 Earnings: Can the Stock Surprise? )
So, do check back on our full earnings release articles on these stocks to see how they’ve finally fared.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.